AKT1 and melanoma: To study such crosstalk in signaling between the MAPK and AKT pathways, we examined whether the treatment of melanoma cells with small molecule inhibitors of one pathway could interfere with the other (Figure 6A,B and Figure S5B,D, respectively for the two pathways).